Symptom association probability and symptom sensitivity index: Preferable but still suboptimal predictors of response to high dose omeprazole

Gut

Volumn 54, Issue 8, 2005, Pages 1067-1071

  Taghavi, S A ^a,b   Ghasedi, M ^c   Saberi Firoozi, M ^b   Alizadeh Naeeni, M ^b   Bagheri Lankarani, K ^b   Kaviani, M J ^b   Hamidpour, L ^b  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ARAK UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

OMEPRAZOLE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST; DRUG MEGADOSE; DRUG RESPONSE; ESOPHAGUS PH; FEMALE; GASTROESOPHAGEAL REFLUX; HUMAN; MALE; OMEPRAZOLE TEST; PH MEASUREMENT; PRIORITY JOURNAL; SCORING SYSTEM; SYMPTOM; SYMPTOM ASSOCIATION PROBABILITY; SYMPTOM SENSITIVITY INDEX; VALIDATION PROCESS;

ADULT; DRUG ADMINISTRATION SCHEDULE; FEMALE; GASTROESOPHAGEAL REFLUX; HEARTBURN; HUMANS; HYDROGEN-ION CONCENTRATION; MALE; MIDDLE AGED; MONITORING, AMBULATORY; OMEPRAZOLE; PROSPECTIVE STUDIES; PROTON PUMPS; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 22644432757     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2004.054981     Document Type: Article

References (14)

1. Bate CM, Riley SA, Chapman RWG, et al. Evaluation of omeprazole as a cost-effective diagnostic test for gastro-oesophageal reflux disease. Aliment Pharmacol Ther 1999;13:59-66.
2. American Gastroenterological Association Medical Position Statement: Guidelines on the use of esophageal pH-recording. Gastroenterology 1996;110:1981-96.
3. Breumelhof R, Smout AJPM. The symptom sensitivity index: A valuable additional parameter in 24-hour esophageal pH recording. Am J Gastroenterol 1991;86:160-4.
4. Weusten BL, Rolfs JMM, Akkermans LMA, et al. The symptom association probability: An improved method for symptom analysis of 24-hour esophageal pH data. Gastroenterology 1994;107:1741-5.
5. Shi G, Bruley D, Varannes S, et al. Reflux related symptoms in patients with normal oesophageal exposure to acid. Gut 1995;37:457-64.
6. Wiener GJ, Richter JE, Copper JB, et al. The symptom index: A clinically important parameter of ambulatory 24-hour esophageal pH monitoring. Am J Gastroenterol 1988;83:358-61.
7. Orr WC. The physiology and philosophy of cause and effect. Gastroenterology 1994;107:1897-901.
8. Numans ME, Lau J, de Wit NJ, et al. Bonis short-term treatment with proton-pump inhibitors as a test for gastroesophageal reflux disease: a meta-analysis of diagnostic test characteristics. Ann Intern Med 2004;140:518-27.
9. Numans ME, Bonis PA, Lau J. Limitations of gold standards for diagnosing gastroesophageal reflux disease. Ann Intern Med 2004;141:648-9.
10. Fass R, Fennerty MB, Ofman JJ, et al. The clinical and economic value of a short course of omeprazole in patients with noncardiac chest pain. Gastroenterology 1998;115:42-9.
11. Fass R, Ofman JJ, Sampliner RE, et al. The omeprazole test is as sensitive as 24-h oesophageal pH monitoring in diagnosing gastro-oesophageal reflux disease in symptomatic patients with erosive esophagitis. Aliment Pharmacol Ther 2000;14:389-96.
12. Schenk BE, Kuipers EJ, Klinkenberg-Knol EC, et al. Omeprazole as a diagnostic tool in gastroesophageal reflux disease. Am J Gastroenterol 1997;92:1997-2000.
13. Colas-Atger E, Bonaz B, Papillon E, et al. Relationship between acid reflux episodes and gastro-esophageal reflux symptoms is very inconstant. Dig Dis Sci 2002;47:645-51.
14. Crawford Clark W. Pain sensitivity and the report of pain: An introduction to sensory decision theory. Anesthesiology 1974;3:272-87.